Vident Advisory’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.11M Buy
148,975
+145
+0.1% +$7.06K 0.06% 269
2026
Q1
$6.38M Sell
148,830
-5,071
-3% -$218K 0.05% 287
2025
Q4
$6.75M Buy
153,901
+3,085
+2% +$128K 0.06% 254
2025
Q3
$6.23M Sell
150,816
-18,573
-11% -$747K 0.06% 261
2025
Q2
$7.47M Sell
169,389
-109,474
-39% -$4.38M 0.08% 201
2025
Q1
$10.3M Buy
278,863
+122,989
+79% +$4.38M 0.15% 133
2024
Q4
$5.19M Buy
155,874
+36,850
+31% +$1.2M 0.09% 201
2024
Q3
$3.09M Buy
+119,024
New +$2.96M 0.08% 269

Other funds holding EXEL

Vident Advisory's EXEL Position: Q2 2026 in Review

Vident Advisory increased its Exelixis (EXEL) stake by 0.1% in Q2 2026, buying an estimated $7.06K and bringing the position to 148,975 shares worth $8.11M. The position accounts for 0.06% of the portfolio, ranked #269.

Vident Advisory first reported a position in EXEL in Q3 2024 and has held it in 8 quarters since. The position peaked at $10.3M in Q1 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Vident Advisory held 148,975 shares of Exelixis worth $8.11M as of Q2 2026.
  • Vident Advisory bought 145 Exelixis shares in Q2 2026, an estimated $7.06K.
  • Exelixis made up 0.06% of Vident Advisory's portfolio in Q2 2026, its #269 holding.
  • Vident Advisory first reported a position in Exelixis in Q3 2024 and has held it in 8 quarters since.
  • Vident Advisory's Exelixis position peaked at $10.3M in Q1 2025.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.